Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Proteome Sciences PLC

PRM.L ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

LSE · Healthcare · Medical Equipment, Supplies & Distribution ·

UK Micro Cap Analyst: N/A

Last Close

$0.02

▼ -3.45%

Market Cap $6.57M · Vol 726.16K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$6.57M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

28.57

Momentum

Beta

0.54

vs Market

52W High

$0.06

67.34% below

52W Low

$0.01

29.73% above

Volume

726.16K

Avg 325.47K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

81.91%

Public shares

Shariah Compliance8 STANDARDS

✗ Proteome Sciences PLC (PRM.L) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PRM.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-22.01%

-12.50%

-18.84%

YTD

-44.00%

-59.54%

-76.42%

-74.31%

Financials & Valuation

TTM · Annual

Total Revenue	$5.06M
Net Income	$-4,124,059.00
Revenue Growth (YoY)	+0.75%
Gross Margin	-2.16%
Operating Margin	-70.98%
Net Profit Margin	-81.50%
ROE	N/A
ROA · ROIC	-41.37% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.96
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	350.72M

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.02
RSI (14)	28.57
Beta	0.54
52-Week High	$0.06
52-Week Low	$0.01

Volume Today	726.16K
Avg Daily Volume (30D)	325.47K
Relative Volume	2.23x
Volatility (10D)	29.88
Volatility (30D)	42.46
Free Float	81.91%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.01 52W High$0.06

Current

Target

$0.01 $0.06

Current Analyst target

· 0 analysts

Identifiers

ExchangeLSE

FIGIBBG001S9B9W0

ISINGB0003104196

CountryUK

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories -0.13% MDT Medtronic PLC +0.18% COR Cencora, Inc. -2.85% BDX Becton Dickinson and Co -0.26% 7741.T HOYA CORPORATION +1.18%

Company Profile

Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.